Alpha Cognition Announces Positive Interim Pre-Clinical Data for Alpha-1062 Use in A Military Relevant Model of Repetitive Mild Traumatic Brain InjuryDec 12
Alpha Cognition Inc. Announces Resignation of Jay Yoo as Interim Principal Accounting and Financial OfficerOct 24
Alpha Cognition Inc. Receives Notice of Allowance for Composition-Of-Matter Patent for ZUNVEYL for Mild to Moderate Alzheimer's DiseaseOct 18